Literature DB >> 34072513

Application of Halloysite Nanotubes in Cancer Therapy-A Review.

Anna Karewicz1, Adrianna Machowska1, Martyna Kasprzyk1, Gabriela Ledwójcik1.   

Abstract

Halloysite, a nanoclay characterized by a unique, tubular structure, with oppositely charged interior and exterior, suitable, nanometric-range size, high biocompatibility, and low cost, is recently gaining more and more interest as an important and versatile component of various biomaterials and delivery systems of biomedical relevance. One of the most recent, significant, and intensely studied fields in which halloysite nanotubes (HNTs) found diverse applications is cancer therapy. Even though this particular direction is mentioned in several more general reviews, it has never so far been discussed in detail. In our review, we offer an extended survey of the literature on that particular aspect of the biomedical application of HNTs. While historical perspective is also given, our paper is focused on the most recent developments in this field, including controlled delivery and release of anticancer agents and nucleic acids by HNT-based systems, targeting cancer cells using HNT as a carrier, and the capture and analysis of circulating tumor cells (CTCs) with nanostructured or magnetic HNT surfaces. The overview of the most up-to-date knowledge on the HNT interactions with cancer cells is also given.

Entities:  

Keywords:  cancer cells; controlled release; halloysite nanotubes; magnetic surfaces; nanostructured surfaces; targeted delivery

Year:  2021        PMID: 34072513     DOI: 10.3390/ma14112943

Source DB:  PubMed          Journal:  Materials (Basel)        ISSN: 1996-1944            Impact factor:   3.623


  57 in total

1.  Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing.

Authors:  Nadine Wong Shi Kam; Zhuang Liu; Hongjie Dai
Journal:  J Am Chem Soc       Date:  2005-09-14       Impact factor: 15.419

2.  Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride.

Authors:  S R Levis; P B Deasy
Journal:  Int J Pharm       Date:  2003-03-06       Impact factor: 5.875

3.  Supramolecular structure of 5-aminosalycilic acid/halloysite composites.

Authors:  Maria-Teresa Viseras; Carola Aguzzi; Pilar Cerezo; Giuseppe Cultrone; Cesar Viseras
Journal:  J Microencapsul       Date:  2008-10-20       Impact factor: 3.142

4.  Large-area assembly of halloysite nanotubes for enhancing the capture of tumor cells.

Authors:  Rui He; Mingxian Liu; Yan Shen; Zheru Long; Changren Zhou
Journal:  J Mater Chem B       Date:  2017-02-13       Impact factor: 6.331

5.  Interfacial Self-Assembly in Halloysite Nanotube Composites.

Authors:  Yuri Lvov; Abhishek Panchal; Ye Fu; Rawil Fakhrullin; Marina Kryuchkova; Svetlana Batasheva; Anna Stavitskaya; Aleksandr Glotov; Vladimir Vinokurov
Journal:  Langmuir       Date:  2019-02-08       Impact factor: 3.882

6.  Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer.

Authors:  Roger M Pallares; Peter Agbo; Xin Liu; Dahlia D An; Stacey S Gauny; Steven E Zeltmann; Andrew M Minor; Rebecca J Abergel
Journal:  ACS Appl Mater Interfaces       Date:  2020-08-26       Impact factor: 9.229

7.  Halloysite Nanotube Coatings Suppress Leukocyte Spreading.

Authors:  Andrew D Hughes; Graham Marsh; Richard E Waugh; David G Foster; Michael R King
Journal:  Langmuir       Date:  2015-12-09       Impact factor: 3.882

Review 8.  Recent advances in targeted nanomedicine as promising antitumor therapeutics.

Authors:  Siddhanth Hejmady; Rajesh Pradhan; Amit Alexander; Mukta Agrawal; Gautam Singhvi; Bapi Gorain; Sanjay Tiwari; Prashant Kesharwani; Sunil Kumar Dubey
Journal:  Drug Discov Today       Date:  2020-10-01       Impact factor: 7.851

9.  Biocompatible TiO2 nanoparticle-based cell immunoassay for circulating tumor cells capture and identification from cancer patients.

Authors:  Rongxiang He; Libo Zhao; Yumin Liu; Nangang Zhang; Boran Cheng; Zhaobo He; Bo Cai; Sizhe Li; Wei Liu; Shishang Guo; Yong Chen; Bin Xiong; Xing-Zhong Zhao
Journal:  Biomed Microdevices       Date:  2013-08       Impact factor: 2.838

10.  Carbon nanotubes in cancer therapy and drug delivery.

Authors:  Abdelbary M A Elhissi; Waqar Ahmed; Israr Ul Hassan; Vinod R Dhanak; Antony D'Emanuele
Journal:  J Drug Deliv       Date:  2011-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.